A mechanistic model for drug release from PLGA-based drug eluting stent: A computational study

Atherosclerosis in the coronary artery is one of the leading causes of death in the world. The stenting as a minimally invasive technique was considered as an effective tool to reduce the severity of atherosclerotic stenosis. In-stent restenosis is the main drawback of the stenting in the coronary artery. Understanding the mechanism of drug release from drug-eluting stents and drug uptake in the arterial wall and obtaining more information about their functionality using mathematical modeling and numerical simulation, could be considered as a predictive tool to investigate in-stent restenosis growth which is experimentally expensive to study. In this work, the local delivery of a therapeutic agent from a PLGA-based bioabsorbable stent implanted in a coronary artery to predict the drug release as well as spatio-temporal drug distribution in a coronary artery with a vulnerable plaque is mathematically modeled and numerically simulated. The effect of copolymer ratio on drug release has been also investigated.

[1]  Wahid Khan,et al.  Drug eluting stents: developments and current status. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  G. Vairo,et al.  Analytical modeling of drug dynamics induced by eluting stents in the coronary multi-layered curved domain. , 2015, Mathematical biosciences.

[3]  S. Hossainy,et al.  Modeling of degradation and drug release from a biodegradable stent coating. , 2007, Journal of biomedical materials research. Part A.

[4]  Jean-Marc Chomaz,et al.  Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall , 2014, Biomechanics and Modeling in Mechanobiology.

[5]  Paolo Zunino,et al.  Multidimensional Pharmacokinetic Models Applied to the Design of Drug-Eluting Stents , 2004 .

[6]  Mario Grassi,et al.  Mathematical modelling and controlled drug delivery: matrix systems. , 2005, Current drug delivery.

[7]  R. Braatz,et al.  Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery. , 2014, Journal of biomechanical engineering.

[8]  Ryo Torii,et al.  Impact of stent strut design in metallic stents and biodegradable scaffolds. , 2014, International journal of cardiology.

[9]  G Dubini,et al.  Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix , 2008, Computer methods in biomechanics and biomedical engineering.

[10]  Yingying Huang,et al.  Drug-eluting biostable and erodible stents. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Giuseppe Pontrelli,et al.  A multi-layer porous wall model for coronary drug-eluting stents , 2010 .

[12]  R. Braatz,et al.  A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion. , 2015, Journal of biomedical materials research. Part A.

[13]  Yun-peng Shang,et al.  Drug-eluting balloons versus drug-eluting stents for the management of in-stent restenosis: A meta-analysis of randomized and observational studies. , 2017, Journal of cardiology.

[14]  A. Tzafriri,et al.  Diffusion‐limited binding explains binary dose response for local arterial and tumour drug delivery , 2009, Cell proliferation.

[15]  J. A. Ferreira,et al.  A coupled non-Fickian model of a cardiovascular drug delivery system. , 2016, Mathematical medicine and biology : a journal of the IMA.

[16]  T. Rabczuk,et al.  The influence of atherosclerotic plaques on the pharmacokinetics of a drug eluted from bioabsorbable stents. , 2017, Mathematical biosciences.

[17]  Elliot L Elson,et al.  A simplified approach to quasi-linear viscoelastic modeling. , 2007, Journal of biomechanics.

[18]  L. Brinson,et al.  Polymer Engineering Science and Viscoelasticity: An Introduction , 2007 .

[19]  Yasuharu Takeda,et al.  Comparison of angioscopic findings among second-generation drug-eluting stents. , 2017, Journal of cardiology.

[20]  T. Rabczuk,et al.  Tuning polymeric and drug properties in a drug eluting stent: A numerical study , 2016 .

[21]  G. Perale,et al.  A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Sean McGinty,et al.  A decade of modelling drug release from arterial stents. , 2014, Mathematical biosciences.

[23]  G. Pontrelli,et al.  A general model of coupled drug release and tissue absorption for drug delivery devices. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Caitríona Lally,et al.  The influence of plaque composition on underlying arterial wall stress during stent expansion: the case for lesion-specific stents. , 2009, Medical engineering & physics.

[25]  R. Ogden,et al.  A New Constitutive Framework for Arterial Wall Mechanics and a Comparative Study of Material Models , 2000 .

[26]  Giuseppe Perale,et al.  Bioresorbable polymer coated drug eluting stent: a model study. , 2012, Molecular pharmaceutics.

[27]  Richard D Braatz,et al.  Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R. Waksman,et al.  Review: Stent fracture in the drug-eluting stent era. , 2016, Cardiovascular revascularization medicine : including molecular interventions.

[29]  Francesco Migliavacca,et al.  Drug release from coronary eluting stents: A multidomain approach. , 2010, Journal of biomechanics.

[30]  Marc D Feldman,et al.  Coronary stents: a materials perspective. , 2007, Biomaterials.

[31]  Thomas Bewley,et al.  Optimization of Drug Delivery by Drug-Eluting Stents , 2015, PloS one.

[32]  S. McKee,et al.  Does anisotropy promote spatial uniformity of stent-delivered drug distribution in arterial tissue? , 2015 .